(BW) (BIO-FLUORESCENT-TECH)(BFTI) BFTI receives Argentinean Health Ministry approval for its rapid immunochromotographic assays for the detection of the HIV 1/2 and Hepatitis "B" viruses Business Wire
click here to return to Business Wire main menu
DonateNow





(BW) (BIO-FLUORESCENT-TECH)(BFTI) BFTI receives Argentinean Health Ministry approval for its rapid immunochromotographic assays for the detection of the HIV 1/2 and Hepatitis "B" viruses

BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 http://www.hnt.com/bizwire - BW1023 DEC 20,1995 5:59 PACIFIC 08:59 EASTERN


SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Dec. 20, 1995-- Bio-Fluorescent Technologies Inc. (OTC BB:BFTI) Wednesday announced the receipt of Health Ministry registration for its rapid assay tests for the HIV 1/2 and Hepatitis "B" virus in Argentina.

Product registration for import was granted Dec. 15, 1995. The company expects to receive its first order from Argentina in January 1996.

These rapid screening assays give results in 7-10 minutes without the requirement of laboratory equipment or trained technicians and can therefore be performed in doctors/dentists waiting rooms, office or at home.

Bio-Fluorescent Technologies Inc. is an international marketing company specializing in leading edge human screening and confirmatory immuno assays including HIV. The company's flagship product known as the MEHICA GP120 combines leading edge satellite imaging technology with state-of-the-art bio-chemistry.

The MEHICA GP120 provides the only mechanized equipment available today to quickly and accurately process immuno-fluorescent assay (IFA) tests.

--30--

CONTACT: Bio Fluorescent Technologies Inc., Scottsdale George, 800/870-1233 or Margaret, 800/665-1335


Keywords: ARIZONA INDUSTRY KEYWORD: MEDICINE BIOTECHNOLOGY

Copyright (c) 1995/BUSINESS WIRE. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854.

KWDarizonaindustrykeyword:medicinebiotechnology
951220
BW951209


Copyright © 1995 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .